11.52
Schlusskurs vom Vortag:
$11.50
Offen:
$11.5
24-Stunden-Volumen:
711.15K
Relative Volume:
0.81
Marktkapitalisierung:
$1.23B
Einnahmen:
$247.00M
Nettoeinkommen (Verlust:
$-249.00M
KGV:
-3.7282
EPS:
-3.09
Netto-Cashflow:
$-267.00M
1W Leistung:
-5.50%
1M Leistung:
+19.13%
6M Leistung:
+18.76%
1J Leistung:
-33.76%
Arcus Biosciences Inc Stock (RCUS) Company Profile
Firmenname
Arcus Biosciences Inc
Sektor
Branche
Telefon
(510) 694-6200
Adresse
3928 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie RCUS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RCUS
Arcus Biosciences Inc
|
11.52 | 1.25B | 247.00M | -249.00M | -267.00M | -3.09 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2024-10-21 | Eingeleitet | H.C. Wainwright | Neutral |
2024-10-08 | Eingeleitet | Wells Fargo | Overweight |
2022-11-18 | Eingeleitet | BofA Securities | Neutral |
2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
2021-10-15 | Fortgesetzt | BTIG Research | Buy |
2020-11-24 | Eingeleitet | Berenberg | Buy |
2020-11-23 | Eingeleitet | Evercore ISI | Outperform |
2020-04-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-03-04 | Eingeleitet | Barclays | Overweight |
2019-11-12 | Eingeleitet | SunTrust | Buy |
2019-09-27 | Eingeleitet | Mizuho | Buy |
2019-05-24 | Fortgesetzt | Citigroup | Buy |
2018-10-09 | Eingeleitet | Wedbush | Outperform |
2018-04-09 | Eingeleitet | Citigroup | Buy |
2018-04-09 | Eingeleitet | Goldman | Neutral |
2018-04-09 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten
Arcus Biosciences, Inc. $RCUS Shares Acquired by Woodline Partners LP - MarketBeat
Arcus Biosciences (NYSE:RCUS) Shares Down 8%Here's What Happened - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Buys 506,853 Shares of Arcus Biosciences, Inc. $RCUS - MarketBeat
Arcus Biosciences, Inc. $RCUS Shares Bought by Granahan Investment Management LLC - MarketBeat
Parkman Healthcare Partners LLC Has $9.54 Million Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Trexquant Investment LP Has $1.69 Million Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Transcript : Arcus Biosciences, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 08 - MarketScreener
PDT Partners LLC Sells 35,454 Shares of Arcus Biosciences, Inc. $RCUS - MarketBeat
Cutter Capital Management LP Invests $5.75 Million in Arcus Biosciences, Inc. $RCUS - MarketBeat
19,300 Stock Options at $12.19: Arcus Biosciences Awards New Employee Inducement Grants - Stock Titan
RA Capital Management L.P. Acquires New Shares in Arcus Biosciences, Inc. $RCUS - MarketBeat
Arcus Biosciences (NYSE:RCUS) Stock Price Up 8.5%Should You Buy? - MarketBeat
Can Arcus Biosciences Inc. keep up with sector leadersMarket Activity Recap & AI Driven Stock Reports - beatles.ru
What analysts say about Arcus Biosciences Inc. stockJuly 2025 Opening Moves & Smart Investment Allocation Tips - 뉴스영
Is Arcus Biosciences Inc. stock bottoming out2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
Using Ichimoku Cloud for Arcus Biosciences Inc. technicalsJuly 2025 Earnings & Technical Buy Zone Confirmations - Newser
Arcus Biosciences Inc.’s volatility index tracking explainedLayoff News & Smart Swing Trading Techniques - Newser
Arcus Biosciences, Inc. $RCUS Shares Acquired by Rafferty Asset Management LLC - MarketBeat
Using data filters to optimize entry into Arcus Biosciences Inc.Long Setup & Fast Exit/Entry Strategy Plans - Newser
There's No Escaping Arcus Biosciences, Inc.'s (NYSE:RCUS) Muted Revenues Despite A 28% Share Price Rise - simplywall.st
Is Arcus Biosciences Inc. stock a smart retirement pickWeekly Profit Report & Daily Profit Focused Screening - خودرو بانک
Nuveen LLC Takes $1.04 Million Position in Arcus Biosciences, Inc. $RCUS - MarketBeat
Azoy Alexander, chief accounting officer, sells Arcus Biosciences shares By Investing.com - Investing.com UK
Why Arcus Biosciences Inc. is moving todayWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
What drives Arcus Biosciences Inc.’s stock priceTake Profit & Community Verified Trade Alerts - خودرو بانک
Strategies to average down on Arcus Biosciences Inc.Weekly Investment Summary & Accurate Buy Signal Alerts - Newser
Smart tools for monitoring Arcus Biosciences Inc.’s price actionJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
What to do if you’re stuck in Arcus Biosciences Inc.2025 Top Gainers & Low Risk Entry Point Guides - Newser
What to expect from Arcus Biosciences Inc. in the next 30 daysEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Is Arcus Biosciences Inc. forming a bottoming baseWeekly Earnings Recap & Fast Entry Momentum Alerts - Newser
What recovery options are there for Arcus Biosciences Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - Newser
Candlestick signals on Arcus Biosciences Inc. stock today2025 Price Momentum & Daily Market Momentum Tracking - Newser
Published on: 2025-09-04 03:31:21 - Newser
Russell Investments Group Ltd. Grows Position in Arcus Biosciences, Inc. $RCUS - MarketBeat
Is Arcus Biosciences Inc. in a long term uptrendTrade Risk Assessment & Risk Managed Investment Entry Signals - خودرو بانک
What machine learning models say about Arcus Biosciences Inc.2025 Biggest Moves & Real-Time Volume Triggers - Newser
Sector ETF performance correlation with Arcus Biosciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Transcript : Arcus Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 11 - MarketScreener
Arcus Biosciences shares rise 7.26% intraday after announcing an Investor Event to highlight new data for its HIF-2a inhibitor casdatifan. - AInvest
Will Arcus Biosciences Inc. see short term momentumJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Arcus Biosciences Inc. stock trend forecastTrade Signal Summary & High Win Rate Trade Tips - Newser
Leading vs lagging indicators on Arcus Biosciences Inc. performanceQuarterly Profit Report & Real-Time Buy Signal Notifications - Newser
Wellington Management Group LLP Makes New $8.50 Million Investment in Arcus Biosciences, Inc. $RCUS - MarketBeat
Applying Wyckoff theory to Arcus Biosciences Inc. stock2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Finanzdaten der Arcus Biosciences Inc-Aktie (RCUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):